aptamer therapeutics for macular degeneration

History:

Eyetech Pharmaceuticals was acquired by OSI Pharmaceuticals in 2005 where it operated as (OSI) Eyetech. OSI ended up divesting itself of its eye-disease assets in 2007. In 2008 the company Eyetech Inc was formed by former OSI employees.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Northeast

Research Focus:
Disease Therapeutics-Research Therapeutics - Development
Therapeutics-Development Therapeutics-Clinical early (I, II) Therapeutics-Clinical late (III, IV)

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: